Fitch mulls ratings downgrade on J&J; Australian GSK aims to disclose doc payments;

@FiercePharma: NEJM data shows Avastin as effective as Lucentis. Item | Follow @FiercePharma

> Fitch Ratings said it is considering downgrading certain ratings for Johnson & Johnson, citing the company's move to buy Swiss medical device maker Synthes Inc. for $21.3 billion. News

> The Australian arm of GlaxoSmithKline will work towards publicly declaring how much it pays individual doctors and other healthcare professionals. Item

> Abbott Laboratories got the FDA nod for a new, higher-concentration version of its testosterone treatment Androgel. Story

> Bowel cancer patients and oncologists are pleading for Australian Prime Minister Julia Gillard's cabinet to approve the listing of the drug Erbitux on the Pharmaceutical Benefits Scheme. Report

> Spanish blood products firm Grifols said it had agreed to sell some of its assets and make commercial agreements that could see its planned $4 billion takeover of rival Talecris approved by U.S. authorities. Article

> Acura Pharmaceuticals said its CEO Andrew Reddick, 58, died on Thursday, while on medical leave from the company. News

Biotech News

 @FierceBiotech:  Oncothyreon raises $40M for cancer work. News | Follow @FierceBiotech

 @JohnCFierce:  Derek Lowe's blog spot is getting a lot of buzz about the Pfizer layoffs coming down. News | Follow @JohnCFierce

> Pfizer's R&D restructuring puts two drug prospects in spotlight. Article 

> Appeals panel endorses federal spending on embryonic stem cell R&D. Story

> FTC deal clears path for Grifols' $4B Talecris buyout. News 

> AZ drops its option on Targacept schizophrenia program. Item 

Biotech IT News

> MIT invents software for building DNA structures. Report

> Computer models aid fight against flu. Story 

> Social networks say they have vital info to add to clinical trials. Item 

> New computational models help solve protein mysteries. Article 

> New tech helping labs go virtual. News

> How can IBM's Watson aid pharma researchers? Story

Medical Device News

> Report: Medtronic CEO to stay on until successor found. Story 

> Nobel Biocare Q1 profit dips, submits bid for Astra Tech. Report 

> Gen-Probe jumps on takeover speculation. News

> FDA looks to reduce exposure to improperly reprocessed devices. Item

> OrSense closes $18M in financing. Story

> Spring-Set Health Solutions gets 510(k) clearance for diabetes treatment. Article

> Brainsway to offer 1.8M shares. News 

And Finally... A drug developed to treat Ewing's Sarcoma, a rare childhood cancer, may also help prevent human prostate cancer from spreading, new lab studies show. Report

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.